knowcompoundsacrylamide
Specimen compound organic compoundPlate I
Acrylamide

- Formula
- C3H5NO
- Molar mass
- 71.079 g/mol
- ChEBI
- CHEBI:28619
- PubChem CID
- 6579
- InChIKey
- HRPVXLWXLXDGHG-UHFFFAOYSA-N
↓ lowered 1 finding · – no difference found
01 · the evidence, ordered
What the evidence says
- Moderate
- 2
- Very limited
- 1
Acrylamide
19 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · findings
What acrylamide moved, and by how much
- SMD standardised mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Pancreatic cancer incidenceMoved: no difference foundEvidence: ModeratePaper: PMID 332664872020
- Who
- 89,729 Japanese men and women aged 45-74 years without prior cancer (JPHC Study), energy-adjusted dietary acrylamide intake by quartile, mean follow-up 15.2 years; whole-cohort result
- Dose studied
- not reported
We observed no association between dietary acrylamide intake and pancreatic cancer (Table 2).”
Quoted verbatim from Dietary Acrylamide Intake and the Risk of Pancreatic Cancer: The Japan Public Health Center-Based Prospective Study.cohortPermalink - Type 2 diabetes incidenceMoved: no difference foundEvidence: ModeratePaper: PMID 372178002023
- Who
- 6022 adults (2707 men, 3315 women) free of diabetes at baseline in the Tehran Lipid and Glucose Study, dietary acrylamide intake by quartile, median follow-up 6.63 years; whole-cohort result
- Dose studied
- not reported
Acrylamide intake was positively associated with the incidence of T2D in model 1 (P for trend = 0.009); however, our results showed no association in model 2 after adjusting for confounding variables.”
Quoted verbatim from The association between dietary acrylamide intake and the risk of type 2 diabetes incidence in the Tehran lipid and glucose study.cohortPermalink - Birth weightMoved: lowersEffect, as reportedSMD−0.05[−0.09 to −0.02]Evidence: Very limitedPaper: PMID 323498552020
- Who
- Offspring of mothers with high versus low gestational dietary acrylamide exposure; pooled five cohort studies (observational)
- Dose studied
- not reported
Offspring's birth weight was significantly lower in high AA exposure group than in low AA exposure group (SMD -0·05, 95 % CI -0·09, -0·02, P = 0·005).”
Quoted verbatim from Relationship between gestational acrylamide exposure and offspring's growth: a systematic review and meta-analysis of cohort studies.meta-analysisPermalink
No row matches these filters.
No dose is advised.
- SMD standardised mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
03 · identity
Structure
- Charge
- 0
- SMILES
- C=CC(N)=O
What the reference databases state
- Reactions · Rhea
- 2reactions
2Reactions
05 · the record
Sources
129
papers screened for acrylamide
- admitted
- 3
- read and discarded
- 21
- not read yet
- 105
Sources cited
3 papers · 3 findings